We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multi-Bay Modular Real Time PCR Instrument Enables Rapid Onsite Nucleic Acid Testing

By LabMedica International staff writers
Posted on 02 Nov 2023
Print article
Image: The MQx96 96-well multi-bay modular qPCR instrument (Photo courtesy of Anitoa Systems)
Image: The MQx96 96-well multi-bay modular qPCR instrument (Photo courtesy of Anitoa Systems)

A new generation of compact and inexpensive molecular testing platforms features a unique ultra-low-light CMOS sensor technology that enables the detection of infectious or oncology markers, as well as pathogens in the food and environment.

Anitoa Systems (Sunnyvale, CA, USA) has launched new 96-well multi-bay modular real-time PCR (qPCR) instruments in its Maverick line of qPCR products. Anitoa's Maverick multi-bay modular qPCR instrument MQx96 is the company’s first larger format qPCR instrument that comes with multiple independently operable modules. The MQx96 and MQx48 instruments are available in 96 (6X16) and 48 (3X16) well formats, and feature 6X or 3X 16-well qPCR modules, both of which can be independently controlled using a unified software interface. MQx96 is ideal for laboratories that are required to run small sample batches continuously in a pipelined manner.

Maverick qPCR instruments feature technological innovations, including a unique proprietary low-light complementary metal-oxide-semiconductor (CMOS) 4-channel fluorescence optics system that enables rapid and highly multiplexed DNA detection. Additionally, Maverick qPCR instruments are easy to use and do not need calibration, thanks to their solid-state construction. Apart from their operational flexibility, Anitoa's MQ96 (and MQ48) are modular systems with each reaction chamber independently heated and cooled. This enables the instruments to achieve a 30-40% faster reaction time compared to traditional large-block qPCR systems.

"We are excited to offer laboratories worldwide a modular solution for rapid and pipelined nucleic acid tests to help combat diseases by detecting pathogens in human, as well as our food and environment," said Dr. Zhimin Ding, CEO of Anitoa Systems. "We believe our multi-bay modular qPCR instruments and the integrated software offer features that meet the needs of labs seeking higher throughput testing while being extremely flexible."

Related Links:
Anitoa Systems

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.